Science
Mechanism of Action
This fusion peptide operates by acting as a cell-communicating ingredient, sending precise signals from the skin's surface to specific receptor sites. This process is intended to inspire the skin's natural repair and regenerative pathways, encouraging the synthesis of essential dermal components such as collagen, elastin, and hyaluronic acid. Such activity is hypothesized to contribute to measurable reductions in wrinkle depth, width, and volume, and to enhance overall skin firmness. It is considered a bioequivalent to Epidermal Growth Factor (EGF), a known cellular signaling molecule that can stimulate cell growth and differentiation; however, its practical efficacy as an EGF mimetic in cosmetic formulations requires further conclusive scientific validation.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 Clinical observations indicate that when HEXAPEPTIDE-40 SH-OLIGOPEPTIDE-1 is incorporated into a water-based blend at concentrations between 1% and 2%, it can demonstrably reduce the depth, width, and volume of wrinkles. However, the scientific community has raised questions regarding the fundamental scientific basis and the proven preclinical bioactivity of sh-oligopeptide-1 (its EGF bioequivalent component), suggesting a need for more robust evidence to support these claims.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
This ingredient is typically supplied within a water-based blend, suggesting this format is optimal for its stability and functional integrity within a formulation.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) has not provided a specific assessment for this exact ingredient, resulting in an 'insufficient data' status. While peptides generally fall under the FDA's 'Generally Recognized as Safe' (GRAS) category, sh-oligopeptide-1 is approved for use in cosmetics at various concentrations. However, comprehensive data on its long-term systemic risks and safety profile remain unavailable.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While some studies indicate a potential for wrinkle reduction, the overall scientific validation of HEXAPEPTIDE-40 SH-OLIGOPEPTIDE-1 as an EGF bioequivalent and its long-term safety profile are currently subject to significant debate and insufficient data, warranting cautious consideration.
Related
Similar Ingredients
Finding similar ingredients…